Bolingas, Anselmo .

HRN: 28-91-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/03/2026
07/09/2026
IV
2.25gm
Q6H
CAP HR And Complicated UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: